Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Jun 12;2014(6):ED000083.
doi: 10.1002/14651858.ED000083.

Treating metastatic breast cancer: the evidence for targeted therapy

Nicholas Wilcken  1
Affiliations
Editorial

Treating metastatic breast cancer: the evidence for targeted therapy

Nicholas Wilcken. Cochrane Database Syst Rev. .
No abstract available

PubMed Disclaimer

Comment on

  • Trastuzumab-containing regimens for metastatic breast cancer.
    Balduzzi S, Mantarro S, Guarneri V, Tagliabue L, Pistotti V, Moja L, D'Amico R. Balduzzi S, et al. Cochrane Database Syst Rev. 2014 Jun 12;2014(6):CD006242. doi: 10.1002/14651858.CD006242.pub2. Cochrane Database Syst Rev. 2014. PMID: 24919460 Free PMC article.

References

    1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER‐2/neu oncogene. Science 1987;235(4785):177–182. doi.org/10.1126/science.3798106 - PubMed
    1. Slamon DJ, Leyland‐Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New England Journal of Medicine 2001;344(11):783–792. doi.org/10.1056/NEJM200103153441101 - PubMed
    1. Balduzzi S, Mantarro S, Guarneri V, Tagliabue L, Pistotti V, Moja L, et al. Trastuzumab‐containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2014;(6):CD006242. doi.org/10.1002/14651858.CD006242.pub2 - PMC - PubMed
    1. Moja L, Tagliabue L, Balduzzi S, Parmelli E, Pistotti V, Guarneri V, et al. Trastuzumab containing regimens for early breast cancer. Cochrane Database of Systematic Reviews 2012;(4):CD006243. doi.org/10.1002/14651858.CD006243.pub2 - PMC - PubMed
    1. Suter TM, Procter M, van Veldhuisen DJ, Muscholl M, Bergh J, Carlomagno C, et al. Trastuzumab‐associated cardiac adverse effects in the Herceptin adjuvant trial. Journal of Clinical Oncology 2007;25(25):3859–3865. doi.org/10.1200/JCO.2006.09.1611 - PubMed

LinkOut - more resources